177 related articles for article (PubMed ID: 21936814)
1. Towards a structural understanding of drug and peptide transport within the proton-dependent oligopeptide transporter (POT) family.
Newstead S
Biochem Soc Trans; 2011 Oct; 39(5):1353-8. PubMed ID: 21936814
[TBL] [Abstract][Full Text] [Related]
2. Peptide transporters: structure, function, regulation and application for drug delivery.
Terada T; Inui K
Curr Drug Metab; 2004 Feb; 5(1):85-94. PubMed ID: 14965252
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2.
Newstead S; Drew D; Cameron AD; Postis VL; Xia X; Fowler PW; Ingram JC; Carpenter EP; Sansom MS; McPherson MJ; Baldwin SA; Iwata S
EMBO J; 2011 Jan; 30(2):417-26. PubMed ID: 21131908
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into substrate recognition in proton-dependent oligopeptide transporters.
Guettou F; Quistgaard EM; Trésaugues L; Moberg P; Jegerschöld C; Zhu L; Jong AJ; Nordlund P; Löw C
EMBO Rep; 2013 Sep; 14(9):804-10. PubMed ID: 23867627
[TBL] [Abstract][Full Text] [Related]
5. Molecular insights into proton coupled peptide transport in the PTR family of oligopeptide transporters.
Newstead S
Biochim Biophys Acta; 2015 Mar; 1850(3):488-99. PubMed ID: 24859687
[TBL] [Abstract][Full Text] [Related]
6. Substrates of the human oligopeptide transporter hPEPT2.
Zhao D; Lu K
Biosci Trends; 2015 Aug; 9(4):207-13. PubMed ID: 26355221
[TBL] [Abstract][Full Text] [Related]
7. Selectivity mechanism of a bacterial homolog of the human drug-peptide transporters PepT1 and PepT2.
Guettou F; Quistgaard EM; Raba M; Moberg P; Löw C; Nordlund P
Nat Struct Mol Biol; 2014 Aug; 21(8):728-31. PubMed ID: 25064511
[TBL] [Abstract][Full Text] [Related]
8. Crystal Structures of the Extracellular Domain from PepT1 and PepT2 Provide Novel Insights into Mammalian Peptide Transport.
Beale JH; Parker JL; Samsudin F; Barrett AL; Senan A; Bird LE; Scott D; Owens RJ; Sansom MSP; Tucker SJ; Meredith D; Fowler PW; Newstead S
Structure; 2015 Oct; 23(10):1889-1899. PubMed ID: 26320580
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2.
Fujita T; Kishida T; Wada M; Okada N; Yamamoto A; Leibach FH; Ganapathy V
Brain Res; 2004 Jan; 997(1):52-61. PubMed ID: 14715149
[TBL] [Abstract][Full Text] [Related]
10. Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.
Nielsen CU; Brodin B
Curr Drug Targets; 2003 Jul; 4(5):373-88. PubMed ID: 12816347
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in understanding prodrug transport through the SLC15 family of proton-coupled transporters.
Minhas GS; Newstead S
Biochem Soc Trans; 2020 Apr; 48(2):337-346. PubMed ID: 32219385
[TBL] [Abstract][Full Text] [Related]
12. Expression of the peptide transporters PepT1, PepT2, and PHT1 in the embryonic and posthatch chick.
Zwarycz B; Wong EA
Poult Sci; 2013 May; 92(5):1314-21. PubMed ID: 23571341
[TBL] [Abstract][Full Text] [Related]
13. Comparison of human and monkey peptide transporters: PEPT1 and PEPT2.
Zhang EY; Emerick RM; Pak YA; Wrighton SA; Hillgren KM
Mol Pharm; 2004; 1(3):201-10. PubMed ID: 15981923
[TBL] [Abstract][Full Text] [Related]
14. Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals.
Parker JL; Deme JC; Wu Z; Kuteyi G; Huo J; Owens RJ; Biggin PC; Lea SM; Newstead S
Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34433568
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in structural biology of peptide transporters.
Terada T; Inui K
Curr Top Membr; 2012; 70():257-74. PubMed ID: 23177989
[TBL] [Abstract][Full Text] [Related]
16. Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.
Viennois E; Pujada A; Zen J; Merlin D
Compr Physiol; 2018 Mar; 8(2):731-760. PubMed ID: 29687900
[TBL] [Abstract][Full Text] [Related]
17. Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
Brandsch M
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):887-905. PubMed ID: 19519280
[TBL] [Abstract][Full Text] [Related]
18. Accurate Prediction of Ligand Affinities for a Proton-Dependent Oligopeptide Transporter.
Samsudin F; Parker JL; Sansom MSP; Newstead S; Fowler PW
Cell Chem Biol; 2016 Feb; 23(2):299-309. PubMed ID: 27028887
[TBL] [Abstract][Full Text] [Related]
19. Proton-coupled oligopeptide transporter (POT) family expression in human nasal epithelium and their drug transport potential.
Agu R; Cowley E; Shao D; Macdonald C; Kirkpatrick D; Renton K; Massoud E
Mol Pharm; 2011 Jun; 8(3):664-72. PubMed ID: 21366347
[TBL] [Abstract][Full Text] [Related]
20. Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2.
Inui K; Terada T; Masuda S; Saito H
Nephrol Dial Transplant; 2000; 15 Suppl 6():11-3. PubMed ID: 11143972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
